Skip to main content
All Posts By

admin

Maryland-Incubator-Company-of-the-Year-logo

Apply now for Maryland Incubator Company of the Year Awards. Deadline: April 18th

By News Archive

Maryland-Incubator-Company-of-the-Year-logo

The 2018 Maryland Incubator Company of the Year Awards publicly recognizes achievements by current clients and graduates of Maryland incubators and provides a forum for the nominees to increase their visibility in the business, technology and investment communities.

Business incubators support new and early-stage businesses in Maryland. In 1986, the first public incubator was established at the University of Maryland in College Park. Recognizing the economic challenges facing new companies, business incubators are facilities that provide reasonable market rents, shared services and technical assistance to start-ups and early-stage companies, including manufacturing, biotech, service and technology firms.

Read More
tedco-3-logo

24 most active nonprofit, public or university investment funds identified – TEDCO Recognized – SSTI

By News Archive

tedco-3-logo

In reviewing data regarding the hundreds of TBED-related investment funds, SSTI found that 24 of them have invested in at least one dozen startups each over the past year.  The funds are characterized as economic development, university-centric, regionally focused, or impact oriented investment funds, incubators and accelerator programs located in the U.S. or Canada. Data the various funds provide to  Pitchbook is the source of the list below, ranked in order by activity level. Each organization may have used their public or university funding to support operations, due diligence or mentoring of portfolio companies and/or to support direct invest into startups.  University-centered activities in the list are denoted by an asterisk at the end of the entry.  Two of the most active 24 funds are nonprofit, impact accelerators supported in part by foundations and corporation philanthropy.

casi-pharmaceutical-logo

CASI Pharmaceuticals’ Evomela Moves Closer to China FDA Approval with Receipt of Advisory Meeting Notice from China Center for Drug Evaluation

By News Archive

casi-pharmaceutical-logo

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces receipt of a letter from the Center for Drug Evaluation (CDE) (group within the China FDA in charge of technical review) indicating that EVOMELA® (melphalan) for injection has been scheduled for review by the Expert Advisory Anti-Tumor (Oncology) Drugs Committee (the “Advisory Committee”), which is scheduled to take place between April 25-26, 2018 (the “Advisory Committee Meeting”).

Read More
nsf-gov-logo

Division of Industrial Innovation & Partnerships – Division Director Employment Opportunity – National Science Foundation

By News Archive

nsf-gov-logo

The National Science Foundation’s Directorate for Engineering (ENG) announces a nationwide search to fill the position of Division Director (DD), Industrial Innovation and Partnerships (IIP). The position provides an unparalleled opportunity to lead the Division to support research, innovation, and entrepreneurship at the forefront of advancing knowledge and stimulating translation of new knowledge into solutions that benefit society; to share in the management responsibility of the Directorate for Engineering to advance NSF’s overall strategic goals “to expand knowledge in science, engineering, and learning, to advance the capability of the nation to meet current and future challenges, and to enhance NSF’s performance of its mission.”

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.